Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4862750 | 0.81 | ADRB2 (1.00) | ADRB2ADRB1 | |
| SCHEMBL5006903 | 0.81 | ADRB2 (1.00) | ADRB2ADRB1 | |
| SCHEMBL4867697 | 0.81 | ADRB2 (1.00) | ADRB2ADRB1 | |
| SCHEMBL4867689 | 0.81 | ADRB2 (1.00) | ADRB2ADRB1 | |
| SCHEMBL4889035 | 0.81 | ADRB2 (1.00) | ADRB2ADRB1 | |
| SCHEMBL4872802 | 0.79 | ADRB2 (1.00) | ADRB2ADRB1 | |
| SCHEMBL3843014 | 0.74 | ADRB2 (0.90) | ADRB2ADRB1 | |
| SCHEMBL3843009 | 0.74 | ADRB2 (0.90) | ADRB2ADRB1 | |
| SCHEMBL13617814 | 0.74 | ADRB2 (0.90) | ADRB2ADRB1 | |
| SCHEMBL13617622 | 0.72 | ADRB2 (1.00) | ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1019075-B9 | BETA 2-ADRENERGIC RECEPTOR AGONISTS | THERAVANCE INC (US) | 2006-08-16 | — | — | EP | claimed |
| EP-1019075-B1 | BETA 2-ADRENERGIC RECEPTOR AGONISTS | THERAVANCE INC (US) | 2005-08-24 | — | — | EP | claimed |